CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,140,000 | +1400.0% | 88,892 | +568.6% | 0.10% | +1385.7% |
| Q2 2021 | $76,000 | -58.7% | 13,295 | -78.6% | 0.01% | -78.1% |
| Q3 2020 | $184,000 | +360.0% | 62,022 | +478.3% | 0.03% | +700.0% |
| Q4 2019 | $40,000 | -93.0% | 10,725 | -90.5% | 0.00% | -87.9% |
| Q1 2019 | $574,000 | +185.6% | 112,568 | +7.7% | 0.03% | +200.0% |
| Q4 2018 | $201,000 | +204.5% | 104,506 | +523.4% | 0.01% | +266.7% |
| Q4 2017 | $66,000 | -14.3% | 16,764 | -44.8% | 0.00% | -25.0% |
| Q3 2017 | $77,000 | – | 30,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |